SK bioscience and VECOL partner on Colombia vaccine manufacturing initiative

SK bioscience has signed a vaccine technology transfer and manufacturing deal with VECOL, becoming part of Colombia’s $260m vaccine localisation initiative. Under the agreement, VECOL will act as the primary implementing partner while SK bioscience contributes technology transfer and manufacturing support. The initial product involved is SKYVaricella, SK bioscience’s varicella vaccine, with plans for broader portfolio expansion in future. Credit: SK bioscience. SK bioscience has signed a vaccine technology transfer and manufacturing agreement with Colombia’s state-owned pharmaceutical company VECOL, becoming part of the country’s $260m vaccine localisation initiative. This move strengthens vaccine supply resilience in Colombia and creates a pathway…

Source: Pharmaceutical Technology